Valar Labs’ CHAI Biomarkers Enhance Bladder Cancer Prediction | New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
The study finds that CHAI (Computational Histology AI) biomarkers stratify [...]
The study finds that CHAI (Computational Histology AI) biomarkers stratify [...]
The study, titled “Augmented reality system for MRI-guided interventions: a [...]
The Phase 2a study EXIST (EXIdavnemab Synucleinopathy Trial), is a [...]
Initial FIH procedures launch FastWave’s multi-center feasibility study evaluating the [...]
Conducted at Samsung Medical Center, the Phase 3 clinical trial [...]
Strategic agreement secures access to essential oncology injectables for clinical [...]
Clinical Global Impression Data Showed Statistically Significant & Clinically Relevant [...]
“Our study shows that widely used large language models have [...]
Trial achieves positive results in the treatment of persistent atrial [...]
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today [...]